WO2014110149A3 - Method of testing or treating the presence of live viruses - Google Patents

Method of testing or treating the presence of live viruses Download PDF

Info

Publication number
WO2014110149A3
WO2014110149A3 PCT/US2014/010705 US2014010705W WO2014110149A3 WO 2014110149 A3 WO2014110149 A3 WO 2014110149A3 US 2014010705 W US2014010705 W US 2014010705W WO 2014110149 A3 WO2014110149 A3 WO 2014110149A3
Authority
WO
WIPO (PCT)
Prior art keywords
site
viral
treating
live viruses
testing
Prior art date
Application number
PCT/US2014/010705
Other languages
French (fr)
Other versions
WO2014110149A2 (en
Inventor
Jon F. STONEBURNER
Ryan ELLIS
Original Assignee
Stoneburner Jon F
Ellis Ryan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoneburner Jon F, Ellis Ryan filed Critical Stoneburner Jon F
Publication of WO2014110149A2 publication Critical patent/WO2014110149A2/en
Publication of WO2014110149A3 publication Critical patent/WO2014110149A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/035—Herpes simplex virus I or II
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2

Abstract

A process to determine the presence of live viruses within viral lesions, such as herpes lesions and warts, in the suspected site on persons or animals is provided. Also provided are methods of treating a viral infection at the site of a viral outbreak on a cutaneous surface of a subject. An aqueous detection reagent solution containing as one example, neutral red and water is applied to the test or treatment site and the test or treatment site to which the reagent has been applied is exposed to an light for a period of time sufficient to detect the presence or absence of the virus or to reduce the number of viral particles at the site.
PCT/US2014/010705 2013-01-08 2014-01-08 Method of testing or treating the presence of live viruses WO2014110149A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361749951P 2013-01-08 2013-01-08
US61/749,951 2013-01-08
US201361908921P 2013-11-26 2013-11-26
US61/908,921 2013-11-26

Publications (2)

Publication Number Publication Date
WO2014110149A2 WO2014110149A2 (en) 2014-07-17
WO2014110149A3 true WO2014110149A3 (en) 2014-11-20

Family

ID=51167499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/010705 WO2014110149A2 (en) 2013-01-08 2014-01-08 Method of testing or treating the presence of live viruses

Country Status (1)

Country Link
WO (1) WO2014110149A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3075616B1 (en) * 2017-12-21 2022-06-10 Oreal METHOD FOR THE TREATMENT OF KERATIN FIBERS USING A DIRECT OXAZONE OR PHENAZINE HALOCHROME DYE, A DEVELOPER AND THEN AN ERASER

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368637B1 (en) * 2001-04-09 2002-04-09 Cross Bay Llc Method and composition for topical treatment of viral lesions
US6855489B1 (en) * 1996-10-28 2005-02-15 Baxter International Inc. Systems and methods for removing viral agents from blood
US20060051214A1 (en) * 2002-08-15 2006-03-09 Tomas Ussing Micro liquid handling device and methods for using it
US20070191675A1 (en) * 2006-02-13 2007-08-16 Joel Gerardo Diaz Sanchez Actinic light colposcope and method to detect lesions in the lower female genital tract produced by human papilloma virus using an actinic light colposcope
US20110250143A1 (en) * 2008-10-24 2011-10-13 Luis Guilherme Da Silva Arnaut Moreira Process for preparing chlorins and their pharmaceutical uses
USRE43274E1 (en) * 2002-06-27 2012-03-27 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US20120270292A1 (en) * 2009-12-21 2012-10-25 Georgia State University Research Foundation Photo-Inactivated Viruses and Systems and Methods of Using the Same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855489B1 (en) * 1996-10-28 2005-02-15 Baxter International Inc. Systems and methods for removing viral agents from blood
US6368637B1 (en) * 2001-04-09 2002-04-09 Cross Bay Llc Method and composition for topical treatment of viral lesions
USRE43274E1 (en) * 2002-06-27 2012-03-27 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US20060051214A1 (en) * 2002-08-15 2006-03-09 Tomas Ussing Micro liquid handling device and methods for using it
US20070191675A1 (en) * 2006-02-13 2007-08-16 Joel Gerardo Diaz Sanchez Actinic light colposcope and method to detect lesions in the lower female genital tract produced by human papilloma virus using an actinic light colposcope
US20110250143A1 (en) * 2008-10-24 2011-10-13 Luis Guilherme Da Silva Arnaut Moreira Process for preparing chlorins and their pharmaceutical uses
US20120270292A1 (en) * 2009-12-21 2012-10-25 Georgia State University Research Foundation Photo-Inactivated Viruses and Systems and Methods of Using the Same

Also Published As

Publication number Publication date
WO2014110149A2 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
WO2014028378A3 (en) Methods and systems for detecting biological components
WO2014015194A3 (en) Methods for detecting and measuring aggregation
MY195999A (en) Molecular Detection/Diagnosis Reagent for Tumor
MY195527A (en) Methods And Systems For Tumor Detection
BR112018007040A2 (en) method and apparatus for detecting and classifying convulsive activity
EP2863309A3 (en) Contextual graph matching based anomaly detection
WO2014118788A3 (en) Early warning system and/or optical monitoring of livestock including poultry
WO2016201450A3 (en) Cancer treatment and diagnosis
EP2472425A3 (en) System and method for detecting unknown malware
EP3345001A4 (en) Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications
EA201391216A1 (en) METHOD AND INSTALLATION TO CONTROL PATIENT TREATMENT, PREFERREDLY TO CONTROL HEMODIALYSIS, HEMODIAFILTRATION AND / OR PERITONEAL DIALYSIS
BR112014000106A2 (en) convulsion detection method and apparatus
MX2016013261A (en) Method for the quantification of parasite eggs in feces.
WO2015066611A3 (en) Microrna profiles in heart failure: methods and systems for detection and use
ES2429425R1 (en) METHOD AND SYSTEM TO DETECT MALINTENTIONED SOFTWARE
WO2015048330A3 (en) On-column viral inactivation methods
MX2016008371A (en) Nucleic acid detection method and kit.
EA201790769A1 (en) DETERMINATION OF THE LEVELS OF GLYCOSAMINOGLICANES BY THE MASS SPECTROMETRY METHOD
WO2012093340A3 (en) Viral diagnostics
EP3287791A4 (en) Method for evaluating coagulation ability of blood specimen, and reagent, reagent kit and device to be used therein
WO2016127077A3 (en) Systems and methods for detection and analysis of biological species
BR112017007946A2 (en) processes and systems for separating seismic data associated with impulsive and non-impulsive sources
MX2021009528A (en) Rgma fragment based diagnostic assay.
PH12016501773A1 (en) Remedial signal generator
WO2014110149A3 (en) Method of testing or treating the presence of live viruses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14737903

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 21/10/2015)

122 Ep: pct application non-entry in european phase

Ref document number: 14737903

Country of ref document: EP

Kind code of ref document: A2